These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26416681)

  • 1. Treatment of Parkinson's disease using cell transplantation.
    Lindvall O
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140370. PubMed ID: 26416681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O
    J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain repair and reprogramming: the route to clinical translation.
    Grealish S; Drouin-Ouellet J; Parmar M
    J Intern Med; 2016 Sep; 280(3):265-75. PubMed ID: 27539906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
    Ramos-Moreno T; Castillo CG; Martínez-Serrano A
    Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell replacement therapy for Parkinson's disease.
    Wijeyekoon R; Barker RA
    Biochim Biophys Acta; 2009 Jul; 1792(7):688-702. PubMed ID: 19007882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?
    Björklund A; Lindvall O
    J Parkinsons Dis; 2017; 7(s1):S21-S31. PubMed ID: 28282811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy for intrastriatal dopaminergic cell transplantation: sequential "nest" grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.
    Timmer M; Nikkhah G
    Exp Cell Res; 2012 Dec; 318(20):2531-42. PubMed ID: 23010385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell therapy for Parkinson's disease: I. Embryonic and adult donor tissue transplantation].
    Anisimov SV
    Adv Gerontol; 2008; 21(4):575-92. PubMed ID: 19432209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy in Parkinson's disease.
    Lindvall O; Björklund A
    NeuroRx; 2004 Oct; 1(4):382-93. PubMed ID: 15717042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: fetal cell or stem cell derived treatments.
    Astradsson A; Aziz T
    BMJ; 2016 Jan; 352():h6340. PubMed ID: 26743154
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of neurological dysfunctions in aphakia mice, a model of Parkinson's disease, after transplantation of ES cell-derived dopaminergic neuronal precursors.
    Chung S; Moon J; Kim KS
    Methods Mol Biol; 2014; 1213():285-91. PubMed ID: 25173391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards stem cell based therapies for Parkinson's disease.
    Parmar M
    Development; 2018 Jan; 145(1):. PubMed ID: 29311261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.